Product Reports Resources Pricing Login Book a demo

Janus Henderson Investors

Other · Founded 1934 · Denver, United States

#500 Investor Ranking 2026 Top 3% of investors worldwide

Helps its clients achieve their long-term financial goals

147 Portfolio companies+68% in 5 years
48 Unicorns
3 Decacorns
209 Investments
Aug 2026 Last investment
02 · Biggest holdings

Janus Henderson Investors’ biggest current holdings.

The most valuable companies Janus Henderson Investors still holds, ordered by Dealroom’s latest valuation. Companies that have been acquired or gone public are in Exits instead. Dealroom has no parsed shareholder register for Janus Henderson Investors, so the size of each stake isn’t shown.

#CompanyValuation
  1. 1 Soul APPUnicorn · Media · China $1.5B
  2. 2 LoadsmartUnicorn · Transportation · USA $1.3B
  3. 3 IntelyCareUnicorn · Health · USA $1.1B
  4. 4 PharmEasyHealth · India $710M
  5. 5 Simba SleepHome Living · UK $26M

Unicorns and thoroughbreds Janus Henderson Investors has backed and still holds, at Dealroom’s latest valuation. See the underlying shareholder registers on Dealroom →

03 · Exits

Janus Henderson Investors’ biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Janus Henderson Investors’ transaction record.

$9.0B IPO · 2022
Now $15BFintech
IPO · 2020
Now $12BHealth
$163M IPO · 2017
Entered Series ANow $10BHealth
$191M IPO · 2021
Entered Series B+Now $8.5BHealth
$174M IPO · 2020
Entered Series B+Now $8.3BHealth
$391M IPO · 2018
Now $7.8BHealth
$250M IPO · 2020
Entered Series B+Now $7.3BHealth
$3.4B IPO · 2019
Entered Series ANow $6.9BHealth
$1.9B IPO · 2021
Entered Series ANow $6.1BHealth
$1.2B IPO · 2024
Entered Series B+Now $5.6BHealth
$275M IPO · 2025
Entered Series B+Now $4.9BHealth
Parabilis Medicines
$2.4B IPO · 2026
Entered Series B+Now $4.8BHealth
04 · Portfolio analysis

Where Janus Henderson Investors’ portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 147 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. USA153
  2. UK8
  3. Canada3
  4. China3
  5. Germany2
  6. India2
  7. Denmark1
  8. France1
  9. Spain1
  10. Switzerland1
By sectorCount
  1. Health160
  2. Transportation5
  3. Fintech4
  4. Energy3
  5. Chemicals1
  6. Consumer Electronics1
  7. Dating1
  8. Engineering and Manufacturing Equipment1
  9. Gaming1
  10. Home Living1
  11. Media1
  12. Real Estate1
By stage enteredCount
  1. Series B+96
  2. Series A25
By growth stageCount
  1. Late Growth143
  2. Breakout Stage26
  3. Mature4
  4. Early Growth3
05 · Portfolio market map

Inside Janus Henderson Investors’ portfolio.

The 60 highest-funded portfolio companies, of 147 tracked.

Magic Leap
Gaming · Unicorn
$2.0B
BioNTech
Health · Unicorn
$6.9B
PharmEasy
Health
$710M
Freenome
Health · Unicorn
$1.3B
Circle
Fintech · Decacorn
$15B
Kailera Therapeutics
Health · Unicorn
$1.9B
HeartFlow
Health · Unicorn
$2.4B
Via
Transportation · Unicorn
$1.5B
Mirion Technologies
Security · Unicorn
$4.7B
Element Biosciences
Health · Unicorn
$1.4B
SomaLogic
Health
Parabilis Medicines
Health · Unicorn
$4.8B
Obsidian Therapeutics
Health
$642M
Maze Therapeutics
Health
$140M
Avidity Biosciences
Health · Decacorn
$12B
Metsera
Health · Unicorn
$4.9B
Solid Biosciences
Health
$541M
Avere Therapeutics
Health · Unicorn
$2.0B
Neurogene
Health
$429M
Structure Therapeutics
Health · Unicorn
$2.4B
Kardium
Health · Unicorn
$1.0B
Olema Oncology
Health
$550M
CesiumAstro
Telecom · Unicorn
$1.1B
Crinetics Pharmaceuticals
Health · Unicorn
$7.8B
Oruka Therapeutics
Health
Galecto | Damora Therapeutics
Health · Unicorn
$1.9B
Scorpion Therapeutics
Health · Unicorn
$2.5B
Annexon Biosciences
Health
$687M
Soul APP
Media · Unicorn
$1.5B
Carmot Therapeutics
Health · Unicorn
$2.7B
Thrive Earlier Detection
Health · Unicorn
$2.2B
Angitia Biopharmaceuticals
Health
$520M
Windward Bio
Health
$825M
Day One Biopharmaceuticals
Health · Unicorn
$1.8B
Verve Therapeutics
Health
$566M
Tyra Biosciences
Health · Unicorn
$1.2B
Tango Therapeutics
Health · Unicorn
$4.1B
Loadsmart
Transportation · Unicorn
$1.3B
Shattuck Labs
Health
$607M
Pyxis Oncology
Health
$214M
Sonoma Biotherapeutics
Health · Unicorn
$1.1B
Aktis Oncology
Health
$807M
CG Oncology
Health · Unicorn
$5.6B
Bicara Therapeutics
Health · Unicorn
$1.3B
Arbor Biotechnologies
Health · Unicorn
$1.1B
Lycia Therapeutics
Health
$300M
LB Pharmaceuticals
Health · Unicorn
$1.0B
Eliem Therapeutics
Health
$494M
Synthekine
Health
$538M
Triveni Bio
Health
$575M
Gracell Biotechnologies
Health
$704M
Vaxcyte
Health · Unicorn
$7.3B
NiKang Therapeutics
Health
$382M
Lexeo Therapeutics
Health
$192M
Ventyx Biosciences
Health
$822M
Chroma Medicine
Health
$540M
Alpha-9 Oncology
Health
$700M
Chinook Therapeutics
Health
$184M
Compass Therapeutics
Health
$216M
Diagonal Therapeutics
Health
$500M
06 · Portfolio founders

Where Janus Henderson Investors’ portfolio founders come from.

155 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States126
  2. United Kingdom4
  3. Denmark3
  4. Germany3
  5. India3
  6. China2
  7. France2
  8. Israel2
  9. Spain2
  10. Australia1
UniversityCount
  1. Harvard University13
  2. Massachusetts Institute of Technology10
  3. Stanford University8
  4. University of California, Berkeley6
  5. Cornell University4
  6. Dartmouth College3
  7. University College London3
  8. University of California, San Diego3
  9. University of Cambridge3
  10. Brandeis University2
Previous companyCount
  1. Novartis7
  2. Dana-Farber Cancer Institute6
  3. McKinsey & Company6
  4. Pfizer4
  5. Scripps Translational Science Institute4
  6. GSK3
  7. Lehman Brothers3
  8. Roche3
  9. Alantos Pharmaceuticals2
  10. Amblyotech2
08 · Key people

Key people at Janus Henderson Investors.

Source: Dealroom next-gen API — investor team endpoint.